Stockscreener 앱 받기
38.39
0.63%
0.24
시간 외 거래:
38.09
-0.30
-0.78%
전일 마감가:
$38.15
열려 있는:
$39.05
하루 거래량:
1.21M
Relative Volume:
1.15
시가총액:
$3.14B
수익:
-
순이익/손실:
$-125.45M
주가수익비율:
-68.55
EPS:
-0.56
순현금흐름:
$-53.89M
1주 성능:
+14.02%
1개월 성능:
+19.93%
6개월 성능:
+144.68%
1년 성능:
+149.77%
1일 변동 폭
$37.80
$39.40
1주일 범위
$31.60
$39.40
52주 변동 폭
$11.39
$39.40
Verona Pharma Plc Adr Stock (VRNA) Company Profile
명칭
Verona Pharma Plc Adr
전화
011-44-0-2032834200
주소
3 MORE LONDON RIVERSIDE, LONDON
Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-05-22 | 재개 | Jefferies | Buy |
| 2022-09-19 | 재개 | Wedbush | Outperform |
| 2022-08-26 | 개시 | Piper Sandler | Overweight |
| 2021-09-13 | 개시 | H.C. Wainwright | Buy |
| 2020-08-25 | 개시 | Jefferies | Buy |
| 2020-08-10 | 개시 | Canaccord Genuity | Buy |
| 2019-04-18 | 개시 | BTIG Research | Buy |
모두보기
Verona Pharma Plc Adr 주식(VRNA)의 최신 뉴스
Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre - Investing.com
Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre By Investing.com - Investing.com UK
Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday - Investing.com Nigeria
Verona Pharma ADR earnings matched, revenue topped estimates By Investing.com - Investing.com UK
Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.
Verona Pharma CFO Mark Hahn sells shares worth $632,760 - Investing.com India
Verona Pharma CEO David Zaccardelli sells shares worth $633,895 - Investing.com India
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma - Barchart
Verona Pharma CEO David Zaccardelli sells $2.25 million in shares - Investing.com India
Verona Pharma CEO David Zaccardelli sells $2.25 million in shares By Investing.com - Investing.com South Africa
Verona Pharma CFO Mark Hahn sells shares worth $2.3 million By Investing.com - Investing.com South Africa
Verona Pharma CFO Mark Hahn sells shares worth $2.3 million - Investing.com India
Market Insights: Verona Pharma Plc ADR (VRNA)’s Notable Drop of -0.55, Closing at 34.07 - The Dwinnex
Verona Pharma Plc ADR [VRNA] Insider Activity: An Update for Investors - Knox Daily
Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily
Verona Pharma Plc ADR (VRNA) stock: A year of ups and downs - US Post News
VRNA Shares Experience Decline in Value - Knox Daily
Financial Metrics Exploration: Understanding Verona Pharma Plc ADR (VRNA) Through Ratios - The Dwinnex
A stock that deserves closer examination: Verona Pharma Plc ADR (VRNA) - US Post News
Wells Fargo gives an Overweight recommendation for Verona Pharma Plc ADR (VRNA) - Knox Daily
Verona Pharma Plc ADR’s (NASDAQ: VRNA) Stock Forecast: Increase To $38 In A Year - Stocks Register
Prepare Yourself for Liftoff: Verona Pharma Plc ADR (VRNA) - SETE News
Verona Pharma Plc ADR [VRNA] stock for 2,254,320 USD was sold by ZACCARDELLI DAVID - Knox Daily
Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains? - Yahoo Finance
Cactus Inc [WHD] Records 50-Day SMA of $59.34 - Knox Daily
Verona Pharma stock soars to all-time high of $30.76 By Investing.com - Investing.com South Africa
Piper Sandler maintains Overweight rating on Verona Pharma shares By Investing.com - Investing.com South Africa
Sea Limited Sponsored ADR (SE) Stock Moves -0.17%: What You Should Know - Yahoo Finance
Verona Pharma stock soars to all-time high of $30.76 - Investing.com
VRNA’s Stock Market Adventure: 58.43% YTD Growth Amidst Volatility - The InvestChronicle
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Moves 6.2% Higher: Will This Strength Last? - Yahoo Finance
MINISO Group Holding Limited Unsponsored ADR (MNSO) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Verona Pharma Plc ADR (VRNA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Investing in Verona Pharma Plc ADR (VRNA) might be a great opportunity, but the stock is a bit overvalued - US Post News
Upcoming Stock Splits This Week (September 30 to October 4) – Stay Invested - Yahoo Finance
Investing in Verona Pharma Plc ADR (VRNA) Is Getting More Attractive - Knox Daily
Li Auto Inc. Sponsored ADR (LI) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Verona Pharma's SWOT analysis: stock soars on Ohtuvayre approval, COPD market potential - Investing.com India
Market Momentum Report: Verona Pharma Plc ADR (VRNA)’s Positive Close at 28.76 - The Dwinnex
Verona Pharma's SWOT analysis: stock soars on Ohtuvayre approval, COPD market potential By Investing.com - Investing.com South Africa
Why Sea Limited Sponsored ADR (SE) Dipped More Than Broader Market Today - Yahoo Finance
Verona Pharma Plc ADR [NASDAQ: VRNA] Sees Decrease in Stock Value - Knox Daily
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
Sea Limited Sponsored ADR (SE) Outperforms Broader Market: What You Need to Know - Yahoo Finance
The growth track for Verona Pharma Plc ADR (VRNA) has changed recently - SETE News
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - Yahoo Finance
Are You Looking for a Top Momentum Pick? Why Taylor Wimpey PLC Unsponsored ADR (TWODY) is a Great Choice - Yahoo Finance
Is America Movil, S.A.B. de C.V. Unsponsored ADR (AMX) Stock Undervalued Right Now? - Yahoo Finance
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
Investor’s Delight: Verona Pharma Plc ADR (VRNA) Closes Weak at 29.60, Down -1.30 - The Dwinnex
Does Verona Pharma Plc ADR (NASDAQ: VRNA) Still Look Hot This Week? - Stocks Register
Verona Pharma Plc Adr (VRNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):